144 related articles for article (PubMed ID: 13545251)
21. [Medico-social considerations on the threatened abortion and habitual abortion and their treatment with hormones].
GIARDINI RG
Sem Med; 1951 Mar; 58(12):427-30. PubMed ID: 14834922
[No Abstract] [Full Text] [Related]
22. [Value of treatment by progesterone in the course of threatened abortion].
de WATTEVILLE H
Ann Ostet Ginecol; 1960 May; 82():484-9. PubMed ID: 13843167
[No Abstract] [Full Text] [Related]
23. Oral therapy in the management of threatened abortion.
SILBERNAGEL WM
Ohio State Med J; 1947 Jul; 43(7):739. PubMed ID: 20248456
[No Abstract] [Full Text] [Related]
24. High potency progesterone drugs and threatened abortion.
HODGKINSON CP; IGNA EJ; BUKEAVICH AP
Am J Obstet Gynecol; 1958 Aug; 76(2):279-87. PubMed ID: 13559316
[No Abstract] [Full Text] [Related]
25. Threatened and habitual abortion.
DAVIS ME
Clin Obstet Gynecol; 1958 Mar; 1(1):219-28. PubMed ID: 13573667
[No Abstract] [Full Text] [Related]
26. [Antihistaminics in threatened abortion].
CAMINITI F
Minerva Ginecol; 1960 Apr; 12():403-16. PubMed ID: 13807178
[No Abstract] [Full Text] [Related]
27. [Contribution to colpocytological interpretation in threatened abortion].
SCARPELLINI L; PEZZALI M
Quad Clin Ostet Ginecol; 1961 Nov; 16():819-29. PubMed ID: 14497841
[No Abstract] [Full Text] [Related]
28. The effect of 17-alpha-methyl-19-nortestosterone (orgasteron) in the treatment of threatened abortion.
BORGLIN NE
Acta Obstet Gynecol Scand; 1960; 39():275-90. PubMed ID: 13802808
[No Abstract] [Full Text] [Related]
29. [The use of a natural smooth muscle relaxant factor in the antispastic therapy of threatened abortion].
GRASSI G
Inf Med; 1961 Mar; 16():61-84. PubMed ID: 13901218
[No Abstract] [Full Text] [Related]
30. Threatened and habitual abortion.
STROMME WB
J Lancet; 1950 Jun; 70(6):225-6; passim. PubMed ID: 15422251
[No Abstract] [Full Text] [Related]
31. [Changes in the estrogen levels in threatened abortion and premature labor].
SULOVIC V; PAJEVIC J; MILOSEVIC B; TOMIC
Bull Fed Soc Gynecol Obstet Lang Fr; 1961; 13():386-95. PubMed ID: 13918337
[No Abstract] [Full Text] [Related]
32. [Sex hormones in therapy of threatened abortion].
GITSCH E
Wien Klin Wochenschr; 1956 May; 68(19):370-3. PubMed ID: 13353033
[No Abstract] [Full Text] [Related]
33. [Management of threatened abortion; preventive therapy of recurring abortion].
PIGEAUD H
Prog Med (Paris); 1951 Jun; 79(12):356-61. PubMed ID: 14854079
[No Abstract] [Full Text] [Related]
34. [Serum therapy in threatened and habitual abortion].
WOLF F
Prakt Arzt; 1951 Jan; 5(44):711-22. PubMed ID: 14816240
[No Abstract] [Full Text] [Related]
35. [The basal thermal curve in threatened abortion and in the prognosis of the appearance of labor].
FALCONE A
Riv Ostet Ginecol Prat; 1961 Jan; 43():34-40. PubMed ID: 15445193
[No Abstract] [Full Text] [Related]
36. [Use of raised doses of chorionic gonadotropins in the treatment of spontaneous habitual abortion].
DURLACH J
Ann Endocrinol (Paris); 1957; 18(6):974-80. PubMed ID: 13521420
[No Abstract] [Full Text] [Related]
37. [On the treatment of threatened abortion with a compound with a 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate (Farlutal) base].
GOISIS M; CAVALLI P; CANDOTTI G
Minerva Ginecol; 1961 Sep; 13():903-5. PubMed ID: 13899588
[No Abstract] [Full Text] [Related]
38. [Nicotinic acid (vitamin PP) therapy of threatened abortion].
PLASTUNOV AB
Akush Ginekol (Mosk); 1959; 35(1):39-42. PubMed ID: 13626736
[No Abstract] [Full Text] [Related]
39. [DIFFERENTIATED CORTICOTHERAPY IN THREATENED PREGNANCIES. VALUE OF THE VAGINAL SMEAR FOR INDICATION AND CONTROL OF TREATMENT].
BADARAU L; DAVID O; MACOVEI D; NACO A; IONITA N
Rev Fr Gynecol Obstet; 1964 Dec; 59():745-84. PubMed ID: 14250303
[No Abstract] [Full Text] [Related]
40. [HORMONAL TREATMENT OF THREATENED ABORTION].
BRUNO RO
Sem Med; 1963 Nov; 123():1701-7. PubMed ID: 14111253
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
